Home / Going-concern warnings / Tonix Pharmaceuticals Holding Corp.
Filed 2026-03-12 路 Form 10-K 路 Accession 0001999371-26-005730 micro
Price before filing: $13.98 (2026-03-11 close, split/dividend-adjusted)
Market cap at flag: $173.7M (2026-03-12) 路 Latest: $100.5M (2026-10-16)
| Window | TNXP | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -7.2% | +1.7% | -8.9% | 2026-04-13 |
| 90 days | -21.6% | +7.6% | -29.2% | 2026-06-10 |
| 180 days | -5.9% | +13.9% | -19.7% | 2026-09-08 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"As discussed in Note 1 to the financial statements, the Company has continuing losses and negative cash flows from operating activities that raise substantial doubt about its ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: independent auditor report in Form 10-K (period 2025-12-31)
Why this score: in auditor's report; also within 90 days: Auditor change
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.